Evaluation of the Effect of a Combination of Plant Extracts (BSL_EP027) on the Incidence of Respiratory Infections

NCT ID: NCT04386408

Last Updated: 2020-05-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-11-30

Study Completion Date

2020-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of the present study is to evaluate the effectiveness of daily consumption of a Combination of Plant Extracts (BSL\_EP027) on the incidence of respiratory infection symptoms and their duration in older healthy volunteers living in a nursing home.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A prevalence of deficient immune state is estimated at 44% of the world's population, a figure that rises in the senior population group.

Traditionally, protection against infection and improvement of the immune response has been addressed through the use of plant extracts. An effective immune response involves the action of both innate and specific responses and the perfect coordination between both. Natural strategies that can activate both types of immune response can lead to more effective treatments.

Our hypothesis is that the different effects of the combination of several plant extracts can lead to a synergy that generates a more effective product in the prevention of respiratory infections, especially in susceptible populations such as the elderly.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Immune Response Respiratory Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Combination of plant extracts (BSL_EP027)

Volunteers will dissolve in water a sachet per day with the Combination of plant extracts (BSL\_EP027), and maltodextrin.

Group Type EXPERIMENTAL

Combination of plant extracts (BSL_EP027)

Intervention Type COMBINATION_PRODUCT

Each participant will consume a sachet disolve in water once at day without any restriction in the diet nor in their habits of life.

Placebo

Volunteers will dissolve in water a sachet per day with maltodextrin.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type COMBINATION_PRODUCT

Each participant will consume a sachet disolve in water once at day without any restriction in the diet nor in their habits of life.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Combination of plant extracts (BSL_EP027)

Each participant will consume a sachet disolve in water once at day without any restriction in the diet nor in their habits of life.

Intervention Type COMBINATION_PRODUCT

Placebo

Each participant will consume a sachet disolve in water once at day without any restriction in the diet nor in their habits of life.

Intervention Type COMBINATION_PRODUCT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Living in a nursing home with medical service.
* Freely accept to participate in the study and sign the informed consent document.

Exclusion Criteria

* Having a disease that affects the development and results of the study.
* Suffer alterations of the state of health incompatible with the continuity in the study.
* Suffer any adverse event not tolerated by the subject.
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Biosearch S.A.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Carlos Gracián, MD

Role: PRINCIPAL_INVESTIGATOR

Doctor of the Claret Nursing Home (Granada, Spain)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Claret Nursing home

Granada, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

C027

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

COVID - AirPollution
NCT04463862 COMPLETED
Functional Implications of TNF
NCT00729131 COMPLETED